13-week oral toxicity study with stanol esters in rats

Regulatory Toxicology and Pharmacology

Volumn 29, Issue 2 I, 1999, Pages 216-226

  Turnbull, Duncan ^a   Whittaker, Margaret H ^a   Frankos, Vasilios H ^a   Jonker, Diana ^b  

^a ENVIRON INTERNATIONAL CORPORATION   (United States)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; FATTY ACID ESTER; PHOSPHOLIPID; PHYTOSTEROL; VITAMIN D; VITAMIN K GROUP;

ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; LIVER LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; VITAMIN BLOOD LEVEL;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0033052887     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1999.1291     Document Type: Article

References (13)

1. Czubayko, F., Beumers, B., Lammfuss, S., Lütjohann, D., and von Bergmann, K. (1991). A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J. Lipid Res. 32, 1861-1867.
2. Gylling, H., and Miettinen, T. A. (1994). Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetology 37, 773-780.
3. Hassan, A. S., and Rampone, A. J. (1979). Intestinal absorption and lymphatic transport of cholesterol and β-sitostanol in the rat. J. Lipid Res. 20, 646-653.
4. Heinemann, T., Kullack-Ublick, G. A., Pietruck, B., and von Bergmann, K. (1991). Mechanism of action of plant sterols on inhibition of cholesterol absorption. Eur. J. Clin. Pharmacol. 40(Suppl. 1), S59-S63.
5. Heinemann, T., Leiss, O., and von Bergmann, K. (1986). Effect of low-dose sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis 61, 219-223.
6. Ikeda, I., Kawasaki, A., Samezima, K., and Sugano, M. (1981). Antihypercholesterolemic activity of β-sitostanol in rabbits. J. Nutr. Sci. Vitamin 27, 243-251.
7. Ikeda, I., and Sugano, M. (1978). Comparison of absorption and metabolism of β-sitosterol and β-sitostanol in rats. Atherosclerosis 30, 227-237.
8. Jones, P. J. H., MacDougall, D. E., Ntanios, F., and Vanstone, C. A. (1997). Dietary phytosterols as cholesterol-lowering agents in humans. Can. J. Physiol. Pharmacol. 75, 217-227.
9. Lütjohann, D., Meese, D. C. I., Crouse, J. R., and von Bergmann, K. (1993). Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in human. J. Lipid Res. 34, 1039-1046.
10. Miettinen, T. A., Puska, P., Gylling, H., Vanhanen, H., and Vartiainen, E. (1995). Reduction of serum cholesterol with sitostanolester margarine in a mildly hypercholesterolemic population. New Engl. J. Med. 333, 1308-1312.
11. Sugano, M., Morioka, H., and Ikeda, I. (1977). A comparison of hypocholesterolemic effect of β-sitosterol and β-sitostanol in rats. J. Nutr. 107, 2011-2019.
12. Vanhanen, H. T., Blomqvist, S., Ehnholm, C., Hyönen, M., Jauhiainen, M., Torstila, I., and Miettinen, T. A. (1993). Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during sitostanol ester treatment. J. Lipid Res. 34, 1535-1544.
13. Vanhanen, H. T., Kajander, J., Lehtovirta, H., and Miettinen, T. A. (1994). Serum levels, absorption efficiency, fecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolemic subjects. Clin. Sci. 87, 61-67.